AACR 2023 – N-Myristolytransferase (NMT) inhibitors as novel potent payloads for antibody drug conjugates
AACR 2023 – From foe to friend: In vivo reprogramming of tumor-associated macrophages to an anti-cancer phenotype by modulating N-myristoyltransferase activity.
AACR 2023 – Dysregulation of MYC-family proteins sensitizes cancers to NMT inhibition: identification of NMTi sensitivity and mechanism.
Publications
Our NMT research has been published in a wide range of prestigious peer reviewed journals.
